Water → ethyl 4,5-dihydro-4-methyl-5-oxo-3H-1,4-benzodiazepine-2-glyoxylate alpha-oxime

HRID 1447355Notes

Reaction equation

HRID 1447355 reaction equation
[CH3:1][N:2]1[C:8](=[O:9])[C:7]2[CH:10]=[CH:11][CH:12]=[CH:13][C:6]=2[NH:5][C:4](=[CH:14][C:15]([O:17][CH2:18][CH3:19])=O)[CH2:3]1.[N+:20]([O-])([O-])=[O:21].[Na+].[OH2:25]>C(O)(=O)C>[CH3:1][N:2]1[C:8](=[O:9])[C:7]2[CH:10]=[CH:11][CH:12]=[CH:13][C:6]=2[N:5]=[C:4]([C:14](=[O:25])[C:15](=[N:20][OH:21])[O:17][CH2:18][CH3:19])[CH2:3]1

Participants

5

Procedure

32.2 g (0.124 mol) of ethyl (1,3,4,5-tetrahydro-4-methyl-5-oxo-2H-1,4-benzodiazepin-2-ylidene)acetate are dissolved in 300 ml of acetic acid and treated at room temperature with 12.8 g (0.186 mol) of sodium nitrate. The mixture is stirred at room temperature for a further 10 minutes, then poured into 1 liter of water and extracted three times with 200 ml of chloroform each time. The combined chloroform phases are washed with 100 ml of water, dried over magnesium sulphate and evaporated. The residue is recrystallised from ethyl acetate. There is obtained ethyl 4,5-dihydro-4-methyl-5-oxo-3H-1,4-benzodiazepine-2-glyoxylate α-oxime of melting point 173°-174° C.

Workup

  1. extractionextracted three times with 200 ml of chloroform each time
  2. washThe combined chloroform phases are washed with 100 ml of water
  3. dry with materialdried over magnesium sulphate
  4. customevaporated
  5. customThe residue is recrystallised from ethyl acetate

Sources & evidence

ORD record
ord-903d6b4e0e5e45f7bed80b3543d6571d
Source dataset
uspto-grants-1982_02
Patent number
US04316839

Reaction notes

Loading…